BR9707772A - Composições farmacêuticas compreendendo alfa-interferon humano natural - Google Patents

Composições farmacêuticas compreendendo alfa-interferon humano natural

Info

Publication number
BR9707772A
BR9707772A BR9707772-0A BR9707772A BR9707772A BR 9707772 A BR9707772 A BR 9707772A BR 9707772 A BR9707772 A BR 9707772A BR 9707772 A BR9707772 A BR 9707772A
Authority
BR
Brazil
Prior art keywords
interferon
natural human
human alpha
pharmaceutical compositions
neoplasia
Prior art date
Application number
BR9707772-0A
Other languages
English (en)
Inventor
Giulio Tarro
Renzo Brozzo
Original Assignee
Ifi Istituto Farmacoterapico I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITRM960136 external-priority patent/IT1283945B1/it
Priority claimed from ITRM960427 external-priority patent/IT1284852B1/it
Application filed by Ifi Istituto Farmacoterapico I filed Critical Ifi Istituto Farmacoterapico I
Publication of BR9707772A publication Critical patent/BR9707772A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES FARMACêUTICAS COMPREENDENDO ALFA-INTERFERON HUMANO NATURAL"<D>. Aplicação de <244>-interferon humano natural para a preparação de um medicamento sob forma líquida a ser administrado através de via peroral a dosagens compreendidas entre 100 UI e 500 UI/dia, para a terapia de infecções virais, em particular hepatite viral, neoplasia e doenças imunes em humanos e animais.
BR9707772-0A 1996-02-28 1997-02-27 Composições farmacêuticas compreendendo alfa-interferon humano natural BR9707772A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM960136 IT1283945B1 (it) 1996-02-28 1996-02-28 Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da
ITRM960427 IT1284852B1 (it) 1996-06-14 1996-06-14 Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da
PCT/IT1997/000040 WO1997031649A1 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON

Publications (1)

Publication Number Publication Date
BR9707772A true BR9707772A (pt) 2000-01-04

Family

ID=26332096

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707772-0A BR9707772A (pt) 1996-02-28 1997-02-27 Composições farmacêuticas compreendendo alfa-interferon humano natural

Country Status (14)

Country Link
US (1) US6884411B1 (pt)
EP (1) EP0886527B1 (pt)
JP (1) JP2000506839A (pt)
KR (1) KR100394382B1 (pt)
AT (1) ATE205397T1 (pt)
AU (1) AU722987B2 (pt)
BR (1) BR9707772A (pt)
DE (1) DE69706657T2 (pt)
DK (1) DK0886527T3 (pt)
EA (1) EA001147B1 (pt)
ES (1) ES2160927T3 (pt)
GE (1) GEP20012489B (pt)
PT (1) PT886527E (pt)
WO (1) WO1997031649A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263552A1 (en) * 2002-09-09 2004-03-29 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
ITMI20030826A1 (it) * 2003-04-18 2004-10-19 Unihart Corp Composizione farmaceutica contenente interferone per il
ES2303492A1 (es) * 2004-08-18 2008-08-01 Instituto Cientifico Y Tecnologico De Navarra S.A. Uso del factor de crecimiento semejante a la insulina tipo i y de interferon alfa en el tratamiento de una enfermedad hepatica cronica, kit y composiciones que los comprenden.
WO2006032711A1 (es) * 2004-08-18 2006-03-30 Instituto Científico Y Tecnológico De Navarra S.A. Uso del factor de crecimiento semejante a la insulina tipo i y de interferón alfa en el tratamiento de una enfermedad hepática crónica, kit y composiciones que los comprenden
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
TW224053B (pt) * 1991-09-13 1994-05-21 Paul B Chretien
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5980884A (en) * 1996-02-05 1999-11-09 Amgen, Inc. Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use

Also Published As

Publication number Publication date
PT886527E (pt) 2001-12-28
ATE205397T1 (de) 2001-09-15
US6884411B1 (en) 2005-04-26
EP0886527A1 (en) 1998-12-30
AU2229997A (en) 1997-09-16
KR100394382B1 (ko) 2004-02-05
DE69706657D1 (de) 2001-10-18
AU722987B2 (en) 2000-08-17
EA001147B1 (ru) 2000-10-30
EA199800770A1 (ru) 1999-02-25
ES2160927T3 (es) 2001-11-16
WO1997031649A1 (en) 1997-09-04
EP0886527B1 (en) 2001-09-12
JP2000506839A (ja) 2000-06-06
GEP20012489B (en) 2001-07-25
KR19990082559A (ko) 1999-11-25
DE69706657T2 (de) 2002-06-20
DK0886527T3 (da) 2002-03-04

Similar Documents

Publication Publication Date Title
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
HUP0102033A2 (hu) PEG IFN-alfa és ribavirin felhasználása krónikus hepatitis C kezelésére
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
ATE165000T1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
DK0527835T3 (da) Doseringsform til afgivelse af et anti-Parkinsonmiddel
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
GEP19981482B (en) Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
HUP9801167A2 (hu) Triaromás vegyületek, azokat tartalmazó kompozíciók és alkalmazásuk
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
HK1068606A1 (en) Novel aminobenzoephenones
BR9707772A (pt) Composições farmacêuticas compreendendo alfa-interferon humano natural
BR0108997A (pt) Terapia imune adjuvante para hiv
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
HUP9902188A2 (hu) Természetes humán alfa-interferont tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]